Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects

Q Ru, Y Li, L Chen, Y Wu, J Min, F Wang - Signal transduction and …, 2024 - nature.com
Iron, an essential mineral in the body, is involved in numerous physiological processes,
making the maintenance of iron homeostasis crucial for overall health. Both iron overload …

Transferrin and transferrin receptors update

H Kawabata - Free Radical Biology and Medicine, 2019 - Elsevier
In vertebrates, transferrin (Tf) safely delivers iron through circulation to cells. Tf-bound iron is
incorporated through Tf receptor (TfR) 1-mediated endocytosis. TfR1 can mediate cellular …

The role of iron in brain ageing and neurodegenerative disorders

RJ Ward, FA Zucca, JH Duyn, RR Crichton… - The Lancet …, 2014 - thelancet.com
In the CNS, iron in several proteins is involved in many important processes such as oxygen
transportation, oxidative phosphorylation, myelin production, and the synthesis and …

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

FA Zucca, J Segura-Aguilar, E Ferrari, P Muñoz… - Progress in …, 2017 - Elsevier
There are several interrelated mechanisms involving iron, dopamine, and neuromelanin in
neurons. Neuromelanin accumulates during aging and is the catecholamine-derived …

Iron in neurodegeneration–cause or consequence?

A Ndayisaba, C Kaindlstorfer… - Frontiers in neuroscience, 2019 - frontiersin.org
Iron dyshomeostasis can cause neuronal damage to iron-sensitive brain regions.
Neurodegeneration with brain iron accumulation reflects a group of disorders caused by iron …

Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential

X Ding, L Gao, Z Han, S Eleuteri, W Shi, Y Shen… - Ageing research …, 2023 - Elsevier
Parkinson's Disease (PD) is characterized by the progressive loss of dopaminergic neurons
in the substantia nigra (SN), leading to motor and non-motor symptoms. While the exact …

Ferroptosis and cell death mechanisms in Parkinson's disease

SJ Guiney, PA Adlard, AI Bush, DI Finkelstein… - Neurochemistry …, 2017 - Elsevier
Symptoms of Parkinson's disease arise due to neuronal loss in multiple brain regions,
especially dopaminergic neurons in the substantia nigra pars compacta. Current therapies …

α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease

R Di Maio, PJ Barrett, EK Hoffman, CW Barrett… - Science translational …, 2016 - science.org
α-Synuclein accumulation and mitochondrial dysfunction have both been strongly implicated
in the pathogenesis of Parkinson's disease (PD), and the two appear to be related …

Clinical quantitative susceptibility mapping (QSM): biometal imaging and its emerging roles in patient care

Y Wang, P Spincemaille, Z Liu, A Dimov… - Journal of magnetic …, 2017 - Wiley Online Library
Quantitative susceptibility mapping (QSM) has enabled magnetic resonance imaging (MRI)
of tissue magnetic susceptibility to advance from simple qualitative detection of hypointense …

Environmental toxins and Parkinson's disease

SM Goldman - Annual review of pharmacology and toxicology, 2014 - annualreviews.org
Parkinson's disease (PD) is a chronic, progressive, disabling neurodegenerative disorder
that begins in mid to late life and is characterized by motor impairment, autonomic …